冯梅头颈部肿瘤放疗综合治疗.PPTVIP

T3-4N0-3M0 RTOG 91.11结论影响更高要求 fit to receive cisplatin will be suitable for treatment with TPF. 亚分型趋势 RT/CCR 新辅助在联合CRT时并没有证明OS 功能保护上联合CRT时应谨慎 亚组分类 N2B/N2C-N3 个体化考虑更适合 术后同步放疗 根据病理亚组制定治疗方案： 化疗药物 分子靶向药物 术后治疗根据亚分型决定 联合多西紫彬超过顺铂 术前放疗 407 patients preoperative low-dose radiotherapy 20 Gy concurrent low-dose chemotherapy with cisplatin (12.5 mg/m2) preoperative radiotherapy was associated with improved survival (p= 0.002) 91 stage III-IV M0 oropharyngeal tumors Group A: RT (69.9 Gy) +?cetuximab? Group B: the same treatment with the addition of 12 weeks of?cetuximab?maintenance?therapy 分子靶向